Prospective analysis of DNA ploidy, Proliferative Index and Epidermal Growth Factor Receptor as prognostic factors for pretreated uterine cancer

Oncology Reports

Volumn 7, Issue 3, 2000, Pages 551-559

  Nagai, Nobutaka ^a   Oshita, Takafumi ^a   Fujii, Tsuneo ^b   Kioka, Hiromasa ^b   Katsube, Yasuhiro ^c   Ohama, Koso ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b National Hospital Organization   (Japan)

^c Kure Kyosai Hospital   (Japan)

Author keywords

Cervical cancer; DNA ploidy; Endometrial cancer; Epidermal growth factor receptor; Prognosis; Proliferative index

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADENOCARCINOMA; ANEUPLOIDY; ARTICLE; CANCER STAGING; DIPLOIDY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; FEMALE; GENETICS; HUMAN; LYMPH NODE METASTASIS; METASTASIS; MITOSIS INDEX; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PLOIDY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL; TIME; UTERINE CERVIX TUMOR; UTERUS CANCER;

ADENOCARCINOMA; ANEUPLOIDY; CARCINOMA, ENDOMETRIOID; CARCINOMA, SQUAMOUS CELL; DIPLOIDY; DNA, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MITOTIC INDEX; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM STAGING; PLOIDIES; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL ANALYSIS; TIME FACTORS; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS;

EID: 0034186060     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.3.551     Document Type: Article

References (32)

1. Zanetta GM, Katzmann JA, Kecney GL, Kinney WK, Cha S and Podratz KC: Flow cytometric DNA analysis of stages IB and IIA cervical carcinoma. Gynecol Oncol 46: 13-19, 1992.
2. Nguyen HN, Sevin B-V, Averette HE, Ganjei P, Perras J, Ramos R, Angioli R, Donato D and Penalver M: The role of DNA index as a prognostic factor in early cervical carcinoma. Gynecol Oncol 50: 54-59, 1993.
3. Kristensen GB, Kaern J, Abeler VM, Hagmar B, Trope CG and Dettersen EO: No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients. Gynecol Oncol 57: 79-85, 1995.
4. Cohnor JP, Miller DS, Bauer KD, Murad TM, Rademaker AW and Lurain JR: Flow cytometric evaluation of early invasive cervical cancer. Obstet Gynecol 81: 367-371, 1993.
5. Jacobsen A, Bichel P, Kristensen GB and Nykland M: Prognostic influence of ploidy level and histopathologic differentiation in cervical carcinoma stage Ib. Eur J Clin Oncol 24: 969-972, 1988.
6. Pfistever J, Kommoss F, Sauerbrei W, Rendle I, Kiechlo M, Kleine W and Pfleiderer A: Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma. Gynecol Oncol 58: 149-156, 1995.
7. Gudmundsson T, Hogberg T, Alm P, Anderson H, Baldotorp P, Ferno M, Langstrom E and Killander D: The prognostic information of DNA ploidy and S-phase fraction may vary with histologic grade in endometrial carcinoma. Acta Oncologica 34: 803-812, 1995.
8. Ikeda M, Watanabe Y, Nanjoh T and Noda K: Evaluation of DNA ploidy in endometrial cancer. Gynecol Oncol 50: 25-29, 1993.
9. Podratz KC, Wilson TO, Guffey TA, Cha SS and Katzmann JA: Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endometrial cancer patients. Am J Obset Gynecol 168: 1206-1215, 1993.
10. Lukes AS, Kohler MF, Pieper CF, Kerns BJ, Bentley R, Rodriguez GC, Soper JT, Clarke-Pearson DL, Bast RC and Berchuck A: Multivariable analysis of DNA ploidy, p53 and HER-2/neu as prognostic factors in endometrial cancer. Cancer 75: 2380-2385, 1994.
11. Carpenter G and Cohen S: Epidermal growth factor. Annu Rev Biochem 48: 193-198, 1979.
12. Sporn MB and Roberts AB: Autocrine growth factors and cancer. Nature 313: 745-747, 1985.
13. Fizpatrick SL, Brightwell J and Wittliff JL: Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progesteron receptor levels. Cancer Res 44: 3448-3453, 1984.
14. Shankey TV, Rabinovitch PS, Bagwell B, Bauer KD, Dugue RE, Hedley DW, Mayall BH and Wheeless L: Guidelines for implementation of clinical DNA cytometry. Cytometry 14: 472-477, 1993.
15. Cox DR: Regression models and life tables. JR Stat Soc B 34: 187-220, 1972.
16. SAS Institute Inc. SAS Technical Report p229. SAS/STAT software: Changes and enhancements. Release 6.07, SAS Inc. Cary, NC, 1992.
17. Strang P, Stendahl U, Bergstrom R, Frankendal B and Tribukait B: Prognostic flow cytometric information in cervical squamous cell carcinoma: a multivariate analysis of 307 patients. Gynecol Oncol 43: 3-8, 1991.
18. Willen R, Trope C, Langstrom E, Ranstam J, Killander D and Clase L: Prospective malignancy grading and flow cytometry DNA distribution in biopsy specimens from invasive squamous cell carcinoma of uterine cervix. Anticancer Res 7: 235-242, 1987.
19. Pietrzak K and Olszewski W: DNA ploidy as a prognostic factor in patient with ovarian carcinoma. Pol J Pathol 49: 141-144, 1998.
20. Baski N, Rajwanshi A, Patel F and Ganguly NK: Prognostic significance of DNA ploidy and S-phase fraction in malignant serous cystadenocarcinoma of ovary. Anal Qvant Cytol Histol 20: 215-220, 1998.
21. Ioakim-Liossi A, Karakitsos P, Aroni K, Delivelioti K, Fortiou V, Fortiou S and Kyrkpu K: p53 protein expression and DNA ploidy in common epithelial tumors of the ovary. Acta Cytol 41: 1714-1718, 1997.
22. Minagawa Y, Kigawa J, Kanamori Y, Itamochi H and Terakawa U: Tumor cell kinetics in elderly patient with cervical cancer. Obstet Gynecol 81: 610-614, 1993.
23. Jacobsen AB, Fossa SD, Thorud E, Lunde S, Melvik JE and Petterson EO: DNA flow cytometric values in bladder carcinoma biopsies obtained from fresh and paraffin-embedded material. APMIS 96: 25-29, 1988.
24. Deitch AD, White RDU and Madewell BR: False DNA aneuploidy in canine and human neoplasms. Anticancer Res 13: 2117-2118, 1993.
25. Tahara E, Sumiyoshi H and Hata J: Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy. Genn 77: 145-150, 1986.
26. Sainsbury JRC, Farndon JR and Sherbet GV: Epidermal growth factor receptors and estrogen receptors in human breast cancer. Lancet 8425: 364-366, 1985.
27. Scambia G, Ferrandina G, Distefano M, P'Agostino G, Benedetti-Panici P and Mancuso S: Epidermal growth factor receptor (EGFR) is not related to the prognosis of cervical cancer. Cancer Lett 123: 135-139, 1998.
28. Altavilla G, Castellan L, Wabersich J, Marchetti M and Ounis A: Prognostic significance of epidermal growth factor receptor (EGFR) and c-erbB-2 protein overexpression in adenocarcinoma of uterine cervix. Eur J Gyneac Oncol 17: 267-270, 1996.
29. Niikura H, Sasano H, Matsunaga G, Watanabe K, Ito K, Sato S and Yajima A: Prognostic value of epidermal growth factor receptor expression in endometrioid endometrial carcinoma. Hum Pathol 26: 892-896, 1995.
30. Scambia G, Benedetti-Panici P, Ferrandia G, Buttaglia F, Distefano M, D'Andrea G, De'Vincenzo R, Maneshi F, Ranelletti FO and Mancuso S: Significance of epidermal growth factor receptor expression in primary human endometrial cancer. Int J Cancer 56: 26-30, 1994.
31. Scambia G, Benedetti-Panici P, Ferrandina G, Distefano M, Salerno B, Romanini ME, Fagotti A and Manouso S: Epidermal growth factor, estrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy. Br J Cancer 72: 361-366, 1995.
32. Fischer-Colbrie J, Witt A, Heinzi H, Speriser P, Czerwenka K, Sevelda P, Zellinger R: EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients. Anticancer Res 17: 613-620, 1997.